A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein
Bioorganic & Medicinal Chemistry · 2025
DOI: 10.1016/j.bmc.2025.118178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025. Verfasst von Mingyang Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai Uni…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Hepatocellular, Cinnamates, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
The RNA methyltransferase methyltransferaselike protein 16 (METTL16) is upregulated in a large proportion of hepatocellular carcinoma (HCC), and its high expression is associated with poor clinical outcomes. METTL16 deletion inhibits HCC growth in vitro and in vivo. Referencing the structure of cinnamic acid, here we designed and synthesized a novel series of small molecular compounds, and found through bioactivity screening that compound 15a effectively reduced METTL16 level and modulated oncogenic PI3K/AKT pathway signaling. Compound 15a inhibited the proliferation and migration of HepG2 cells, and induced apoptosis in vitro. Furthermore, compound 15a significantly inhibited the growth of patient-derived HCC xenografts in nude mice with greater efficacy than the multi-kinase inhibitor lenvatinib. The promising efficacy and good biosafety profile of compound 15a enables us to further develop this compound for treating patients with HCC and possibly other cancers in clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China; Qi…
- Qingdao Central Hospital, School of Health and Life Sciences, University of Health and Rehabilitation Sciences, No. 369 Dengyun Road, Qingdao 266113, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China. El…
- Cancer and Stem Cell Program, Duke-NUS Medical School, 8 College Road, 169857 Singapore, Singapore. Electronic address: hu.jiancheng@nccs.com.sg.
- State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Tiancheng Drug Assessment Co., Ltd, Tianjin 300193, Chinaa. Electronic address: hujf@tjipr.com.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Liu, M., Ke, M., Lu, H., Feng, Z., Wang, K., Wang, D., Wang, K., Bai, Y., Yang, S., Miao, L., Chen, Q., Sun, M., Shan, C., Hu, J., Jiang, L., Jin, H., Hu, J., Huang, C., Wang, R., …, & Yu, F. (2025). A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2025.118178
Vancouver
Liu M, Ke M, Lu H, Feng Z, Wang K, Wang D, et al. A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein. Bioorganic & Medicinal Chemistry. 2025. doi:10.1016/j.bmc.2025.118178
BibTeX
@article{Liu2025,
author = {Liu, Mingyang and Ke, Muyan and Lu, Hongchen and Feng, Ziyu and Wang, Kaixuan and Wang, Danyang and Wang, Kun and Bai, Yueping and Yang, Song and Miao, Lu and Chen, Qiang and Sun, Mingming and Shan, Changliang and Hu, Jiancheng and Jiang, Lingyu and Jin, Hongzhen and Hu, Jinfang and Huang, Changjiang and Wang, Rui and Zhao, Wei and Yu, Fan},
title = {A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein},
journal = {Bioorganic & Medicinal Chemistry},
year = {2025},
doi = {10.1016/j.bmc.2025.118178}
}
EUVIMED